Israel Englander G1 Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $871,218 - $2 Million	414,866 Added 1336.29%	445,912 $1.93 Million
Q4 2023 Feb 14, 2024	SELL	$1.12 - $3.73 $646,261 - $2.15 Million	-577,019 Reduced 94.89%	31,046 $94,000
Q2 2023 Aug 14, 2023	SELL	$2.46 - $3.14 $656,989 - $838,596	-267,069 Reduced 30.52%	608,065 $1.51 Million
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $2.05 Million - $6.5 Million	-796,725 Reduced 47.66%	875,134 $2.35 Million
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $2.59 Million - $6.74 Million	499,363 Added 42.59%	1,671,859 $9.08 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $2.3 Million - $7.55 Million	444,376 Added 61.03%	1,172,496 $14.6 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $2.44 Million - $5.14 Million	603,926 Added 486.28%	728,120 $3.6 Million
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $453,188 - $657,122	59,630 Added 92.36%	124,194 $944,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $655,970 - $1.04 Million	64,564 New	64,564 $659,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $2.5 Million - $4.64 Million	-142,237 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$10.99 - $20.4 $4.55 Million - $8.44 Million	-413,700 Reduced 74.41%	142,237 $2.56 Million
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $6.42 Million - $13.2 Million	555,937 New	555,937 $6.42 Million
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $1.31 Million - $3.34 Million	-137,024 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$9.07 - $26.32 $281,442 - $816,709	-31,030 Reduced 18.46%	137,024 $1.51 Million
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $2.44 Million - $3.68 Million	-118,700 Reduced 41.39%	168,054 $4.44 Million
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $3.6 Million - $6.42 Million	158,094 Added 122.88%	286,754 $6.53 Million
Q2 2019 Aug 15, 2019	BUY	$16.03 - $31.1 $215,026 - $417,175	13,414 Added 11.64%	128,660 $3.95 Million
Q2 2019 Aug 14, 2019	SELL	$16.03 - $31.1 $595,161 - $1.15 Million	-37,128 Reduced 24.37%	115,246 $1.14 Million
Q1 2019 May 14, 2019	BUY	$14.4 - $21.45 $1.99 Million - $2.97 Million	138,353 Added 986.76%	152,374 $2.53 Million
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $231,486 - $719,697	14,021 New	14,021 $269,000
Q2 2018 Aug 14, 2018	SELL	$35.06 - $51.17 $623,962 - $910,672	-17,797 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $339,032 - $743,202	17,797 New	17,797 $659,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account